Brainsway (BWAY) Share-based Compensation (2018 - 2026)
Brainsway (BWAY) posted quarterly Share-based Compensation of $342000.0 for Q1 2026, up 5.23% year-on-year from $325000.0 in Q1 2025, and up 21.71% on a QoQ basis from $281000.0 in Q4 2025.
Brainsway (BWAY) Share-based Compensation (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Share-based Compensation for 9 consecutive years, with $342000.0 the latest figure, recorded in Q1 2026.
- Quarterly Share-based Compensation rose 5.23% year-over-year to $342000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 77.25% YoY) and the FY2025 annual result came in at $1.2 million, down 16.93% from the prior year.
- Share-based Compensation grew to $342000.0 in Q1 2026 per BWAY's latest filing, from $281000.0 in the prior quarter.
- Over the last five years, Share-based Compensation for BWAY reached as high as $5.5 million in Q3 2024 and fell as low as -$51000.0 in Q1 2023.
- A 5-year average of $599411.8 and a median of $339000.0 in 2022 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation slumped 113.64% — and 2024, when it surged 5656.84%.
- Year by year, Share-based Compensation stood at $353000.0 in 2022, then plunged by 33.71% to $234000.0 in 2023, then surged by 64.1% to $384000.0 in 2024, then dropped by 26.82% to $281000.0 in 2025, then climbed by 21.71% to $342000.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $342000.0, $281000.0, and $638000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 342,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 342,000.00 |
| Mar 31, 2026 | 342,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Sep 30, 2025 | 638,000.00 |
| Sep 30, 2025 | 638,000.00 |
| Jun 30, 2025 | 227,000.00 |
| Jun 30, 2025 | 227,000.00 |
| Mar 31, 2025 | 325,000.00 |
| Mar 31, 2025 | 325,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Sep 30, 2024 | 5.47 Mn |
| Sep 30, 2024 | 5.47 Mn |
| Jun 30, 2024 | 364,000.00 |
| Jun 30, 2024 | 364,000.00 |
| Mar 31, 2024 | 305,000.00 |
| Mar 31, 2024 | 305,000.00 |
| Dec 31, 2023 | 234,000.00 |
| Dec 31, 2023 | 234,000.00 |